Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 2 |
2023 | 3 |
2024 | 1 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
The effect of GP-2250 on cultured virus-negative Merkel cell carcinoma cells: preliminary results.
J Cancer Res Clin Oncol. 2023 Sep;149(12):10831-10840. doi: 10.1007/s00432-023-04960-3. Epub 2023 Jun 14.
J Cancer Res Clin Oncol. 2023.
PMID: 37311987
Free PMC article.
Substance GP-2250 as a New Therapeutic Agent for Malignant Peritoneal Mesothelioma-A 3-D In Vitro Study.
Baron C, Buchholz M, Majchrzak-Stiller B, Peters I, Fein D, Müller T, Uhl W, Höhn P, Strotmann J, Braumann C.
Baron C, et al. Among authors: majchrzak stiller b.
Int J Mol Sci. 2022 Jun 30;23(13):7293. doi: 10.3390/ijms23137293.
Int J Mol Sci. 2022.
PMID: 35806313
Free PMC article.
Item in Clipboard
Next-generation microbiological testing in intraabdominal infections with PCR technology.
Horn J, Höhn P, Strotmann J, Majchrzak-Stiller B, Buchholz M, Uhl W, Herzog T.
Horn J, et al. Among authors: majchrzak stiller b.
Langenbecks Arch Surg. 2024 Apr 3;409(1):108. doi: 10.1007/s00423-024-03298-9.
Langenbecks Arch Surg. 2024.
PMID: 38570375
Free PMC article.
Item in Clipboard
In Vitro Experiments on the Effects of GP-2250 on BRAF-Mutated Melanoma Cell Lines and Benign Melanocytes.
Gambichler T, Harnischfeger F, Skrygan M, Majchrzak-Stiller B, Buchholz M, Müller T, Braumann C.
Gambichler T, et al. Among authors: majchrzak stiller b.
Int J Mol Sci. 2023 Oct 19;24(20):15336. doi: 10.3390/ijms242015336.
Int J Mol Sci. 2023.
PMID: 37895015
Free PMC article.
Item in Clipboard
GP-2250, a novel anticancer agent, inhibits the energy metabolism, activates AMP-Kinase and impairs the NF-kB pathway in pancreatic cancer cells.
Majchrzak-Stiller B, Buchholz M, Peters I, Waschestjuk D, Strotmann J, Höhn P, Hahn S, Braumann C, Uhl W, Müller T, Möhler H.
Majchrzak-Stiller B, et al.
J Cell Mol Med. 2023 Jul;27(14):2082-2092. doi: 10.1111/jcmm.17825. Epub 2023 Jun 30.
J Cell Mol Med. 2023.
PMID: 37390227
Free PMC article.
Item in Clipboard
New Therapy Options for Neuroendocrine Carcinoma of the Pancreas-The Emergent Substance GP-2250 and Gemcitabine Prove to Be Highly Effective without the Development of Secondary Resistances In Vitro and In Vivo.
Buchholz M, Strotmann J, Majchrzak-Stiller B, Hahn S, Peters I, Horn J, Müller T, Höhn P, Uhl W, Braumann C.
Buchholz M, et al. Among authors: majchrzak stiller b.
Cancers (Basel). 2022 May 29;14(11):2685. doi: 10.3390/cancers14112685.
Cancers (Basel). 2022.
PMID: 35681665
Free PMC article.
Item in Clipboard
Cite
Cite